Please login to the form below

Not currently logged in
Email:
Password:

RPSGB promotes excellence In pharmacy research

The Royal Pharmaceutical Society of Great Britain (RPSGB) has awarded the University of Nottingham's School of Pharmacy with a platform to promote the next generation of research talent.

The Royal Pharmaceutical Society of Great Britain (RPSGB) has awarded the University of Nottingham's School of Pharmacy with a platform to promote the next generation of research talent.

The School of Pharmacy will host an Academic Excellence Award in 2008, which is a prestigious programme of PhD studentships offered by the RPSGB.

Nottingham was one of only two UK institutions selected from among 23 applicants, after a judging process involving a panel of distinguished pharmacy academics.

The RPSGB Academic Excellence Awards hope to increase the number of pharmacists who enter and stay in academia as a career by providing funding to enable exceptional pharmacists and pharmacy graduates to undertake PhD training. The scheme promotes the important role played by members of the academic workforce in developing and leading the profession of pharmacy.

The University will host an award for research with the title 'Selective inhibitors for nuclear receptors: an alternative to anti-hormone therapies', supervised by Professor David Heery. This work investigates the mechanisms by which genes are switched on or off in healthy or diseased human cells.

The award is only the latest accolade for the highly-rated School of Pharmacy. In April this year the School won a Queen's Award for Enterprise in the category of Innovation. Cardiff University was the other institution to be successful in the Academic Excellence Awards for 2008.

20th August 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....